#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute graft versus host disease in skin Cervix carcinoma recurrent Ataxia telangiectasia Hereditary hypophosphataemic rickets MELAS syndrome Parkinson's disease Progressive familial intrahepatic cholestasis Cutaneous T-cell lymphoma Squamous cell carcinoma of the oral cavity B-cell small lymphocytic lymphoma refractory Acute lymphocytic leukaemia recurrent Necrotising enterocolitis neonatal Biotinidase deficiency Hyperoxaluria Autoimmune myositis More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome – Trials in Disease Rhabdomyosarcoma – Life with Disease Chondrosarcoma Pemphigoid – Basic Information Waldenstrom’s macroglobulinaemia refractory – Basic Information Activated PI3 kinase delta syndrome – Trials in Disease Andersen-Tawil syndrome – Diagnostics Sjogren’s syndrome Idiopathic pulmonary fibrosis – Basic Information Toxic epidermal necrolysis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gliclazide Etuvetidigene Autotemcel Haemophilus Influenzae Imatinib Lazertinib Casirivimab Myrrh Travoprost Terbinafine Hydrochloride Mavorixafor Cenerimod Levothyroxine Sodium Quercetin Empasiprubart Davutamig Sirexatamab THEOPHYLLINE ANHYDROUS Gemcitabine Hydrochloride Paeonol Naproxen More therapies…

    Learn about Your Condition

    Oropharyngeal cancer recurrent Hepatic cancer Atrophic vulvovaginitis Thymoma Gestational diabetes Papillary thyroid cancer Chronic fatigue syndrome Urticaria Neurotrophic keratopathy Optic atrophy Bone marrow failure Atopic keratoconjunctivitis Retinopathy proliferative Stress Pneumonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bipolar disorder

  • A Study of OSU6162 in Adults with Bipolar Depression to Evaluate Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • 3-(3-Methanesulfonyl-Phenyl)-1-Propyl-Piperidine Hydrochloride
    Sweden

  • Effect of Adjunctive Pramipexole on Anhedonia in Adults with Bipolar Depression – Randomized, Double‑Blind, Placebo‑Controlled Phase III Trial

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Pramipexole
    Sweden

  • Study on Vitamin D for Patients with Depression or Bipolar Disorder

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar disorder
    • Depression
    Investigated Drugs:
    • Colecalciferol
    Italy

  • Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    • Schizophrenia
    • Bipolar disorder
    Investigated Drugs:
    • Lithium
    • Clozapine
    • Esketamine
    Austria Germany Italy Spain

  • Study on the Effects of Etifoxine in Treating Depression in Patients with Unipolar or Bipolar Disorder

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Bipolar disorder
    • Depression
    Investigated Drugs:
    • Etifoxine Hydrochloride
    Germany

  • Study on Amiloride for Treating Nephrogenic Diabetes Insipidus in Bipolar Disorder Patients on Long-term Lithium Therapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Amiloride
    France
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!